Controversies about the treatment of myasthenia gravis.
Clinicians treating patients with myasthenia gravis must choose cholinergic drugs, corticosteroids, immunosuppressive drugs, thymectomy, or plasmapheresis. Clinicians must decide the sequence or combination of these therapies and when to deem lack of improvement a sign for a different therapeutic ap...
Zapisane w:
| Wydane w: | J Neurol Neurosurg Psychiatry |
|---|---|
| 1. autor: | |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMJ Publishing Group
1980
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC490631/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7400825/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.43.7.644 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|